Krinwave

Established in 2019, and based in Shenzhen, China, Krinwave specializes in advanced ultrasound technology, primarily focusing on improving imaging solutions for medical professionals. In January 2025, Krinwave closed series A+ funding led by new investor Tencent Investment, with participation from new investors Zhongxiaodan Venture Capital, G&O, Qianhai Ark Asset Management, Hengqin Financial Investment, returning investor Sherpa Healthcare Partners, and other unspecified investors. Krinwave Technology specializes in advanced ultrasound imaging solutions, prominently featuring their proprietary kOS imaging platform. The kOS platform integrates groundbreaking technologies such as full-mode planar waves, super-resolution beamforming (SRBF), and ultra-penetrative (UP) probes, thereby achieving an unprecedented combination of deep tissue penetration and spatial resolution.

These innovations culminate in superior imaging capabilities that enhance diagnostic performance in various medical applications, particularly within neurology, spine assessment, gastrointestinal evaluation, and pulmonary diagnostics. Their products are designed to cater to medical professionals and institutions in diverse markets, including Asia, Europe, and North America, with a client base that includes hospitals, clinics, and research facilities focused on improving ultrasound imaging techniques. The company generates revenue by developing ultrasound imaging equipment.